These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1573342)

  • 1. Change in the thyroid function by use of deferoxamine in a patient with hemochromatosis complicated by hyperthyroidism.
    Kubota K; Kurabayashi H; Tamura J; Kawada E; Tamura K; Nagashima K; Shirakura T
    J Med; 1992; 23(1):75-7. PubMed ID: 1573342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between the depth of inverted T waves and the serum level of ferritin in a deferoxamine-treated patient with primary hemochromatosis and hyperthyroidism.
    Kurabayashi H; Kubota K; Tamura J; Yanagisawa T; Shirakura T
    Jpn J Med; 1989; 28(2):243-6. PubMed ID: 2733248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid disease in hemochromatosis. Increased incidence in homozygous men.
    Edwards CQ; Kelly TM; Ellwein G; Kushner JP
    Arch Intern Med; 1983 Oct; 143(10):1890-3. PubMed ID: 6625774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term efficacy of subcutaneous administration of deferoxamine in patients with secondary hemochromatosis].
    Kobayashi M; Yano K; Fujisawa S
    Rinsho Ketsueki; 1996 Apr; 37(4):303-10. PubMed ID: 8847800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM
    Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twin pregnancy with a coexisting hydatiform mole and liveborn infant: complicated by maternal hyperthyroidism and neonatal hypothyroidism.
    True DK; Thomsett M; Liley H; Chitturi S; Cincotta R; Morton A; Cotterill A
    J Paediatr Child Health; 2007 Sep; 43(9):646-8. PubMed ID: 17688651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term intraperitoneal deferoxamine for hemochromatosis.
    Swartz RD; Legault DJ
    Am J Med; 1996 Mar; 100(3):308-12. PubMed ID: 8629676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T3 toxicosis in adolescence: presentation as recurrent hyperthyroidism.
    AvRuskin TW; Tang S; Shenkman L; Hollander CS
    Pediatrics; 1973 Nov; 52(5):649-52. PubMed ID: 4126724
    [No Abstract]   [Full Text] [Related]  

  • 9. Neonatal hemochromatosis: failure of deferoxamine therapy.
    Jonas MM; Kaweblum YA; Fojaco R
    J Pediatr Gastroenterol Nutr; 1987; 6(6):984-8. PubMed ID: 3681586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parameters of serum binding of thyroxine in hypo-, hyper- and euthyroidism and their application to the control of therapy.
    Gordon A; Kleinerman H; Ehrenfeld M; Ehrenfeld E
    Isr J Med Sci; 1971 Sep; 7(9):1029-34. PubMed ID: 5004887
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myocardiopathy caused by iron deposition. Treatment with chelating agents].
    Rodríguez Reguero JJ; Iglesias Cubero G; Espolita Santos A; López de la Iglesia JM; Enríquez Martín J; Tomás Mauri J; López-Negrete L
    Rev Esp Cardiol; 1985; 38(5):356-7. PubMed ID: 4081244
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of primary hemochromatosis with deferoxamine.
    Young N; Henry W; Nienhuis AW
    JAMA; 1979 Mar; 241(11):1152-4. PubMed ID: 762769
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemochromatosis complicating hyperthyroidism].
    Ueoka H; Fujiwara K; Kimura I
    Rinsho Ketsueki; 1985 Oct; 26(10):1636-40. PubMed ID: 4094080
    [No Abstract]   [Full Text] [Related]  

  • 15. Spontaneous thyrotoxicosis in infancy: report of a case.
    Levitsky LL; Trias E; Grossman MS
    Pediatrics; 1970 Oct; 46(4):627-9. PubMed ID: 4100772
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of desferrioxamine B and 2-(beta-aminoethoxy)cyclohexylaminetetraacetate in experimental hemochromatosis in rats and in primary hemochromatosis of man].
    Bohne F; Lessmann J
    Arzneimittelforschung; 1969 Jun; 19(6):944-7. PubMed ID: 5820039
    [No Abstract]   [Full Text] [Related]  

  • 17. An unusual cause of syncope: hyperthyroidism.
    Ozaydin M; Türker Y; Doğan A; Varol E; Aslan SM; Altinbaş A
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):453-4. PubMed ID: 18065353
    [No Abstract]   [Full Text] [Related]  

  • 18. Childhood hyperthyroidism. Report on 39 cases.
    Mäenpää J; Hiekkala H; Lamberg BA
    Acta Endocrinol (Copenh); 1966 Mar; 51(3):321-36. PubMed ID: 4160462
    [No Abstract]   [Full Text] [Related]  

  • 19. Ambulatory blood pressure monitoring in patients with hyperthyroidism before and after control of thyroid function.
    Iglesias P; Acosta M; Sánchez R; Fernández-Reyes MJ; Mon C; Díez JJ
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):66-72. PubMed ID: 15963064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthyroidism in a 3-month-old baby.
    Leszynsky HE; Gross-Kieselstein E; Abrahamov A
    Pediatrics; 1971 Jun; 47(6):1069-73. PubMed ID: 4258884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.